Ewopharma is the successor company to M.R. Leclerc & Co., founded in 1959. From the start, our focus has been on building bridges to the pharmaceutical markets of Central Eastern Europe. Much has changed in the region since 1959 – both economically and politically – and over this period we have gained an in-depth understanding of the markets and an esteemed standing there.
While we started out purely as a marketing partner for pharmaceutical companies, we have since acquired and launched proprietary products. Our brand Revalid® – a product line for holistic hair care and hair loss treatment–was developed in 1992 in Switzerland. In 2011, we acquired Irish healthcare company Newport Pharmaceuticals Ltd. giving us full ownership of the antiviral drug Isoprinosine® in 2011.Overseen by our head office in Schaffhausen, Switzerland, we now channel our industry knowledge and experience into the successful placement of both Ewopharma and partner brands in our target markets. In 2004, we joined the RX-Alliance, a professional cooperation network of successful pharmaceutical companies active in selected European markets.

Pharmaceutical

Ewopharma

Alain Staub

Reto Schaberl

Antonio Mantarro

Andreas Kübler

The Business Management team at Ewopharma is responsible for strategically overseeing and optimizing the performance of various product lines and market segments across Central Eastern Europe. This team consists of dedicated Business Unit and Country Managers who collaborate to drive sales, enhance market presence, and ensure successful product positioning for both Ewopharma's proprietary offerings and partner brands in their respective regions. Their expertise in local markets allows them to navigate complex regulatory environments and consumer needs, fostering growth and profitability for the company.

Business Management

About

Team members

Other teams at Ewopharma

Marketing and Sales

Medical and Regulatory Affairs